---  
layout: startup_page  
title: "ENYO Pharma"  
id: "enyopharma.com"  
permalink: "/enyopharmaenyopharma.com01032024/"  
website: "https://www.enyopharma.com/"  
funding_round: "Series C"  
funding_amount: "€39M"  
investors: "OrbiMed, Morningside Ventures, AndEra Partners, Bpifrance InnoBio, Bpifrance Large Ventures"  
about: "ENYO Pharma is a biotechnology company developing therapeutics for diseases with impaired kidney function. Their lead candidate, Vonafexor, is a highly selective FXR agonist with anti-inflammatory and fibrolytic properties, currently in a Phase 2 clinical trial for Alport Syndrome. The company also has a fast-follower compound, EYP651, with similar properties."  
markets: "Biotechnology, Pharmaceuticals, Renal Diseases, Biopharma, Medical"  
hq: "Lyon, Auvergne-Rhône-Alpes, France"  
founded_year: "2014"  
linkedin: "https://www.linkedin.com/company/enyo-pharma/"  
twitter: "https://twitter.com/enyopharma"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/enyo-pharma"  
pitchbook: "https://pitchbook.com/profiles/company/149476-60"  

date_display: "03-Jan-2024"  
date: "2024-01-03"

# SEO Optimization  
meta_title: "ENYO Pharma - Series C Funding (€39M)"  
meta_description: "ENYO Pharma, ENYO Pharma is a biotechnology company developing therapeutics for diseases with impaired kidney function. Their lead candidate, Vonafexor, is a highl..."  
meta_keywords: "ENYO Pharma, Biotechnology, Pharmaceuticals, Renal Diseases, Biopharma, Medical, Series C funding"  
canonical_url: "https://startup.projectstartups.com/enyopharmaenyopharma.com01032024/"  
---